Radx tech - mammoth biosciences detection of sars-COV-2 with the crispr-based detectr platform under radx tech
Ended Definitive Contract Awarded Last action
- Contract number
- 75N92020C00011
- Awardee
-
Mammoth Biosciences Inc. UEI SMF2ALZMSRA5
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $20,800,000
Award facts
- Contract value 100% obligated
- $20,800,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- South San Francisco, CA 94080, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | $0 | |
| Supplemental Agreement for work within scope | -$2,281,269 | |
| Supplemental Agreement for work within scope | $0 | |
| Definitize Letter Contract | $13,931,269 | |
| Original award | $9,150,000 |
About this award
Mammoth Biosciences Inc., doing business as Mammoth Diagnostics, has been awarded a $20.8 million firm fixed price definitive contract by the National Institutes of Health's National Heart, Lung, and Blood Institute to support the RADX Tech program. Under this contract, Mammoth Diagnostics will utilize its CRISPR-based Detectr platform to develop assays for the detection of SARS-CoV-2, the virus that causes COVID-19. The work will be performed in South San Francisco, California over an 18-month period ending in January 2022. The RADX Tech program aims to accelerate diagnostic testing for COVID-19 and future pandemic threats through the NIH's Rapid Acceleration of Diagnostics initiative. No set aside designation was specified.
Quick answers
Who was awarded contract 75N92020C00011?
75N92020C00011 was awarded to Mammoth Biosciences Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on July 30, 2020.
How much is contract 75N92020C00011 worth?
The government has obligated $20,800,000 on 75N92020C00011.
Was contract 75N92020C00011 competed?
The extent of competition for 75N92020C00011 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award